首页> 外文期刊>Peptides: An International Journal >Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.
【24h】

Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.

机译:血管活性肠肽可通过抑制NADPH氧化酶减少胰腺腺泡细胞的氧化应激。

获取原文
获取原文并翻译 | 示例
       

摘要

Vasoactive intestinal peptide (VIP) attenuates experimental acute pancreatitis (AP) by inhibition of cytokine production from inflammatory cells. It has been suggested that reactive oxygen species (ROS) as well as cytokines play pivotal roles in the early pathophysiology of AP. This study aimed to clarify the effect of VIP on the oxidative condition in pancreas, especially pancreatic acinar cells (acini). Hydrogen peroxide (H(2)O(2))-induced intracellular ROS, assessed with CM-H(2)DCFDA, increased time- and dose-dependently in acini isolated from rats. Cell viability due to ROS-induced cellular damage, evaluated by MTS assay, was decreased with >/=100 mumol/L H(2)O(2). VIP significantly inhibited ROS production from acini and increased cell viability in a dose-dependent manner. Expression of antioxidants including catalase, glutathione reductase, superoxide dismutase (SOD) 1 and glutathione peroxidase was not altered by VIP except for SOD2. Furthermore, Nox1 and Nox2, major components of NADPH oxidase, were expressed in pancreatic acini, and significantly increased after H(2)O(2) treatment. Also, NADPH oxidase activity was provoked by H(2)O(2). VIP decreased NADPH oxidase activity, which was abolished by PKA inhibitor H89. These results suggested that VIP affected the mechanism of ROS production including NADPH oxidase through induction of a cAMP/PKA pathway. In conclusion, VIP reduces oxidative stress in acini through the inhibition of NADPH oxidase. These results combined with findings of our previous study suggest that VIP exerts its protective effect in pancreatic damage, not only through an inhibition of cytokine production, but also through a reduction of the injury caused by oxidative stress.
机译:血管活性肠肽(VIP)通过抑制炎症细胞产生的细胞因子来减轻实验性急性胰腺炎(AP)。已经表明,活性氧(ROS)和细胞因子在AP的早期病理生理中起着关键作用。这项研究旨在阐明VIP对胰腺尤其是胰腺腺泡细胞(acini)氧化状态的影响。过氧化氢(H(2)O(2))诱导的细胞内ROS,用CM-H(2)DCFDA评估,增加了从大鼠中分离出的痤疮的时间和剂量依赖性。通过MTS分析评估,由于ROS诱导的细胞损伤而导致的细胞生存力以> / = 100 mumol / L H(2)O(2)降低。 VIP以剂量依赖的方式显着抑制痤疮引起的ROS产生并增加细胞活力。除SOD2外,VIP不会改变过氧化氢酶,谷胱甘肽还原酶,超氧化物歧化酶(SOD)1和谷胱甘肽过氧化物酶等抗氧化剂的表达。此外,Nox1和Nox2,NADPH氧化酶的主要成分,在胰腺腺泡中表达,并在H(2)O(2)处理后显着增加。此外,NADPH氧化酶的活性是由H(2)O(2)引起的。 VIP降低了NADPH氧化酶活性,这被PKA抑制剂H89消除。这些结果表明,VIP通过诱导cAMP / PKA途径影响了ROS产生的机制,包括NADPH氧化酶。总之,VIP通过抑制NADPH氧化酶来降低痤疮的氧化应激。这些结果与我们先前研究的发现相结合,表明VIP不仅通过抑制细胞因子的产生,而且通过减少氧化应激引起的损伤,在胰腺损伤中发挥其保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号